Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Belief Biomed Limited currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This workload is concentrated under 1 distinct examiner and 1 distinct art unit, indicating a highly focused prosecution environment. For a practitioner, this concentration suggests that the outcome of the entire pending portfolio relies on a single point of contact at the USPTO. The centralized nature of this prosecution means that the legal strategy does not need to account for varying interpretations across different USPTO departments or multiple art units.
The busiest examiner for this portfolio is PERSONS, JENNA L, who is responsible for 1 busiest examiner pending action. Because the total pending office actions and the busiest examiner pending actions are identical, this examiner handles the entirety of the company's current active prosecution. This allows for a consistent communication strategy, as no other examiners are involved in the current pending matters. Practitioners can focus their efforts on understanding the specific preferences and history of PERSONS, JENNA L within the 1 distinct art unit involved. This singular focus simplifies the administrative burden of tracking multiple examiner responses and deadlines across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERSONS, JENNA L | 1 | 50.8% | +61.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17604995 | A NEW TYPE OF ENZYME COMPOSITION | PERSONS, JENNA L | 5d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17604995 | A NEW TYPE OF ENZYME COMPOSITION | PERSONS, JENNA L | 5d overdue |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17604995 | A NEW TYPE OF ENZYME COMPOSITION | PERSONS, JENNA L | 1637 | §101§102§103§112 | Non-Final OA | 5d overdue | Pending | Oct 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBelief Biomed Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jenna L Persons has the most, with 1 of Belief Biomed Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
